Chesley Taft & Associates LLC Sells 370 Shares of CME Group Inc (CME)

Share on StockTwits

Chesley Taft & Associates LLC trimmed its position in shares of CME Group Inc (NASDAQ:CME) by 10.1% during the third quarter, HoldingsChannel reports. The firm owned 3,300 shares of the financial services provider’s stock after selling 370 shares during the period. Chesley Taft & Associates LLC’s holdings in CME Group were worth $562,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in CME. Janus Henderson Group PLC raised its position in shares of CME Group by 13.2% during the second quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock worth $1,004,691,000 after acquiring an additional 716,655 shares during the last quarter. Renaissance Technologies LLC bought a new position in shares of CME Group during the second quarter worth about $96,350,000. Unigestion Holding SA bought a new position in shares of CME Group during the second quarter worth about $96,251,000. KAMES CAPITAL plc bought a new position in shares of CME Group during the second quarter worth about $85,187,000. Finally, Standard Life Aberdeen plc raised its position in shares of CME Group by 38.1% during the second quarter. Standard Life Aberdeen plc now owns 1,765,929 shares of the financial services provider’s stock worth $289,472,000 after acquiring an additional 487,442 shares during the last quarter. 84.03% of the stock is currently owned by hedge funds and other institutional investors.

CME has been the subject of a number of analyst reports. Jefferies Financial Group restated a “buy” rating and set a $190.00 price objective on shares of CME Group in a research report on Wednesday, September 5th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a report on Wednesday, August 22nd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Saturday, August 18th. Rosenblatt Securities assumed coverage on CME Group in a report on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 target price for the company. Finally, Berenberg Bank set a $184.00 target price on CME Group and gave the stock a “hold” rating in a report on Thursday, September 20th. Five analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $178.93.

In other news, President Bryan T. Durkin sold 11,509 shares of the business’s stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the completion of the sale, the president now owns 64,862 shares in the company, valued at $10,508,292.62. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Ronald A. Pankau sold 260 shares of the business’s stock in a transaction that occurred on Thursday, August 9th. The shares were sold at an average price of $163.17, for a total value of $42,424.20. Following the sale, the director now owns 3,900 shares of the company’s stock, valued at approximately $636,363. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 26,688 shares of company stock valued at $4,523,957. Corporate insiders own 0.43% of the company’s stock.

Shares of CME stock opened at $176.50 on Friday. The company has a market capitalization of $57.79 billion, a price-to-earnings ratio of 37.08, a price-to-earnings-growth ratio of 3.20 and a beta of 0.64. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.15. CME Group Inc has a fifty-two week low of $132.33 and a fifty-two week high of $182.97.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.02. The business had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The firm’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.22 earnings per share. On average, research analysts anticipate that CME Group Inc will post 6.64 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 25th. Stockholders of record on Monday, September 10th were issued a dividend of $0.70 per share. The ex-dividend date was Friday, September 7th. This represents a $2.80 annualized dividend and a dividend yield of 1.59%. CME Group’s dividend payout ratio is 58.70%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Article: Should you buy a closed-end mutual fund?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply